circulating levels bromocriptine vaginal oral administration circulating levels bromocriptine oral vaginal administration drug DESIGN Experimental PARTICIPANTS Seven female volunteers hyperprolactinemic patient INTERVENTIONS Ovulatory volunteers oral vaginal bromocriptine mg second session subjects crossed-over alternate route additional hyperprolactinemic patient vaginal bromocriptine MAIN OUTCOME MEASURE Serum bromocriptine prolactin PRL levels hours normal volunteers hours hyperprolactinemic patient RESULTS Circulating bromocriptine levels vaginal bromocriptine hour reduction serum PRL oral administration hours CONCLUSIONS bromocriptine reduction overall dose compliance therapeutic efficacy 